These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 17979707

  • 1. Human endometrial and ovarian cancer cells: histone deacetylase inhibitors exhibit antiproliferative activity, potently induce cell cycle arrest, and stimulate apoptosis.
    Takai N, Narahara H.
    Curr Med Chem; 2007; 14(24):2548-53. PubMed ID: 17979707
    [Abstract] [Full Text] [Related]

  • 2. A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Int J Mol Med; 2006 Feb; 17(2):323-9. PubMed ID: 16391833
    [Abstract] [Full Text] [Related]

  • 3. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.
    Ueda T, Takai N, Nishida M, Nasu K, Narahara H.
    Int J Mol Med; 2007 Feb; 19(2):301-8. PubMed ID: 17203205
    [Abstract] [Full Text] [Related]

  • 4. M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Gynecol Oncol; 2006 Apr; 101(1):108-13. PubMed ID: 16263156
    [Abstract] [Full Text] [Related]

  • 5. CBHA is a family of hybrid polar compounds that inhibit histone deacetylase, and induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Matsuda K, Kusumoto M, Narahara H.
    Oncology; 2006 Apr; 70(2):97-105. PubMed ID: 16601366
    [Abstract] [Full Text] [Related]

  • 6. Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis.
    Takai N, Kawamata N, Gui D, Said JW, Miyakawa I, Koeffler HP.
    Cancer; 2004 Dec 15; 101(12):2760-70. PubMed ID: 15536623
    [Abstract] [Full Text] [Related]

  • 7. Anticancer activity of MS-275, a novel histone deacetylase inhibitor, against human endometrial cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Anticancer Res; 2006 Dec 15; 26(2A):939-45. PubMed ID: 16619490
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Beta-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Gynecol Oncol; 2008 Apr 15; 109(1):107-14. PubMed ID: 18234298
    [Abstract] [Full Text] [Related]

  • 11. Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cells.
    Takai N, Ueda T, Nasu K, Narahara H.
    Gynecol Oncol; 2008 Nov 15; 111(2):336-43. PubMed ID: 18790523
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cucurbitacin D induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial and ovarian cancer cells.
    Ishii T, Kira N, Yoshida T, Narahara H.
    Tumour Biol; 2013 Feb 15; 34(1):285-91. PubMed ID: 23150173
    [Abstract] [Full Text] [Related]

  • 14. C2-ceramide exhibits antiproliferative activity and potently induces apoptosis in endometrial carcinoma.
    Takai N, Ueda T, Kawano Y, Nishida M, Nasu K, Narahara H.
    Oncol Rep; 2005 Nov 15; 14(5):1287-91. PubMed ID: 16211298
    [Abstract] [Full Text] [Related]

  • 15. K252a is highly effective in suppressing the growth of human endometrial cancer cells, but has little effect on normal human endometrial epithelial cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Oncol Rep; 2008 Mar 15; 19(3):749-53. PubMed ID: 18288411
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. PK11195 enhances chemosensitivity to cisplatin and paclitaxel in human endometrial and ovarian cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Int J Mol Med; 2010 Jan 15; 25(1):97-103. PubMed ID: 19956907
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cytostatic and apoptotic effects of DNMT and HDAC inhibitors in endometrial cancer cells.
    Xu S, Ren J, Chen HB, Wang Y, Liu Q, Zhang R, Jiang SW, Li J.
    Curr Pharm Des; 2014 Jan 15; 20(11):1881-7. PubMed ID: 23888960
    [Abstract] [Full Text] [Related]

  • 20. Histone deacetylase inhibitor therapy in epithelial ovarian cancer.
    Takai N, Narahara H.
    J Oncol; 2010 Jan 15; 2010():458431. PubMed ID: 20052384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.